References
- Park M, Liu G T, Piltz-Seymour J, Wisda C L, Rook A H, Junkins-Hopkins J M, et al. Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy. Leuk Lymphoma 2007; 48: 808–811
- Ruddle J B, Prince H M. Denileukin diftitox and vision loss. Leuk Lymphoma 2007; 48: 655–656
- Takeuchi M, Keino H, Kezuka T, Usui M, Taguchi O. Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice. Invest Ophthalmol Vis Sci 2004; 45: 1879–1886
- Ruddle J B, Harper C A, Honemann D, Seymour J F, Prince H M. A denileukin diftitox (Ontak) associated retinopathy?. Br J Ophthalmol 2006; 90: 1070–1071
- Baig M N, Lubow M, Immesoete P, Bergese S D, Hamdy E A, Mendel E. Vision loss after spine surgery: review of the literature and recommendations. Neurosurg Focus 2007; 23: E15
- Sadda S R, Nee M, Miller N R, Biousse V, Newman N J, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 2001; 132: 743–750
- Chang S H, Miller N R. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience. Spine 2005; 30: 1299–1302
- Lee L A, Roth S, Posner K L, Cheney F W, Caplan R A, Newman N J, et al. The American Society of Anesthesiologists Postoperative Visual Loss Registry: analysis of 93 spine surgery cases with postoperative visual loss. Anesthesiology 2006; 105: 652–659, quiz 867 – 868